ORIGINAL RESEARCH
Accepted on 25 Mar 2025
A real-world pharmacovigilance study of efgartigimod alfa in the FDA Adverse Event Reporting System database
doi 10.3389/fphar.2025.1510992
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- Advances in Drug-induced Diseases Volume II
Advances in Drug-induced Diseases Volume II
28k
Total downloads
124k
Total views and downloads
Articles
SYSTEMATIC REVIEW
Published on 19 Mar 2025
Immune checkpoint inhibitors-induced pancreatitis: a systematic review and real-world pharmacovigilance analysis
doi 10.3389/fphar.2025.1426847
- 131 views
ORIGINAL RESEARCH
Published on 10 Mar 2025
Signal detection and safety analysis of three tyrosine kinase inhibitors for HER-2 positive breast cancer: a retrospective study based on the FAERS database
doi 10.3389/fphar.2025.1538881
- 196 views
ORIGINAL RESEARCH
Published on 18 Feb 2025
Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database
doi 10.3389/fphar.2025.1459067
- 515 views
ORIGINAL RESEARCH
Published on 13 Feb 2025
Real-world pharmacovigilance investigation of imipenem/cilastatin: signal detection using the FDA Adverse Event Reporting System (FAERS) database
doi 10.3389/fphar.2025.1524159
- 570 views
ORIGINAL RESEARCH
Published on 24 Jan 2025
Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults
doi 10.3389/fphar.2025.1524702
- 613 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Overweight and glucose/lipid metabolism abnormality associated with SSRIs: a pharmacovigilance study based on the FDA adverse event reporting system
doi 10.3389/fphar.2024.1517546
- 927 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases
doi 10.3389/fphar.2024.1466875
- 1,037 views
ORIGINAL RESEARCH
Published on 03 Jan 2025
The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model
doi 10.3389/fphar.2024.1505653
- 357 views
ORIGINAL RESEARCH
Published on 18 Dec 2024
Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system
doi 10.3389/fphar.2024.1486422
- 962 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study
doi 10.3389/fphar.2024.1502047
- 909 views
ORIGINAL RESEARCH
Published on 11 Dec 2024
A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system
doi 10.3389/fphar.2024.1438661
- 762 views
- 1 citation
Published in
Frontiers in Pharmacology
Gastrointestinal and Hepatic Pharmacology
Pharmacology of Anti-Cancer Drugs
Pharmacoepidemiology
Pharmacology of Infectious Diseases
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore